Changes in the rate of cholesterol synthesis in lymphocytes, and blood lipid and lipoprotein levels in patients with ischemic heart disease and hypercholesterolemia during treatment with lovastatin and obsidan
Poliakova, E.D.; Ivanova, T.N.; Nikulina, S.E.; Metel'skaia, V.A.; Olfer'ev, A.M.; Shcherbakova, I.A.; Akhmedzhanov, N.M.; Perova, N.V.
Biulleten' Eksperimental'noi Biologii i Meditsiny 117(3): 248-251
1994
ISSN/ISBN: 0365-9615 PMID: 8204840 Document Number: 424887
Document emailed within 1 workday
Related Documents
Perova, N.V.; Bubnova, M.G.; Aronov, D.M.; Zhidko, N.I.; Olferév, A.M.; Akhmedzhanov, N.M. 1993: Effect of lovastatin on serum lipid and apolipoprotein levels after dietary fat load in patients with ischemic heart disease Kardiologiia 33(4): 8-10Ivanova, T.N.; Poliakova, E.D.; Olfer'ev, A.M.; Perova, N.V. 1998: Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia Biulleten' Eksperimental'noi Biologii i Meditsiny 125(5): 569-573
Kalinina, A.M.; Chazova, L.V.; Perova, N.V.; Pavlova, L.I.; Shchepkin, V.V. 1993: An increased risk of death from ischemic heart disease in men with low blood concentrations of total cholesterol and low-density lipoprotein cholesterol Terapevticheskii Arkhiv 65(4): 27-32
Tijerina, O.; Dombrovskis, S.; Esper, E.; Matts, J.P.; Campos, C.T.; Buchwald, H. 1988: Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits Surgery 104(4): 796-805
Kudriakova, S.V.; Suntsov, I.I.; Slavina, L.S.; Mazovetskii, A.G. 1984: HDL cholesterol lipoprotein levels and the atherogenicity coefficient in males with diabetes mellitus and ischemic heart disease Kardiologiia 24(11): 40-43
Vakhliev, V.D.; Bogatyrev, I.V.; Uchaĭkina, L.V.; Syrkin, A.L. 1988: Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease Kardiologiia 28(10): 36-39
Idzior-Waluś, B. 1992: Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration Przeglad Lekarski 49(10): 327-333
Gavrilova, R.D.; Khanina, S.B.; Simonov, V.V.; Puntus, K.K.; Zybin, O.K. 1987: Blood lipid levels in various forms of ischemic heart disease Kardiologiia 27(10): 51-55
Bodnar, P.N.; Donish, R.M.; Panasiukova, O.R. 1984: Significance of high-density lipoprotein cholesterol in the development of ischemic heart disease in diabetes mellitus patients Problemy Endokrinologii 30(3): 19-24
Pistulková, H.; Písa, Z.; Poledne, R.; Kaucká, J.; Drozdová, V.; Skodová, Z.; Petrzilková, Z.; Paclt, M.; Hanousek, L.; Valenta, Z. 1992: Serum lipid and lipoprotein levels in children in relation to their dietary habits and parental blood cholesterol Ceskoslovenska Pediatrie 47(1): 13-18
Forti, N.; Ramires, J.A. 1991: Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. a Brazilian multicenter study Arquivos Brasileiros de Cardiologia 57(3): 253-261
Ianovskiĭ, G.V.; Shevchuk, S.G.; Girina, N.I.; Petrusha, G.N. 1978: Preventive treatment of ischemic heart disease with obsidan and nerobolil under ambulatory conditions Vrachebnoe Delo 1978(6): 16-18
Borisov, A.V. 1988: Effectiveness of combined administration of obsidan and sidnofarm in patients with ischemic heart disease at a polyclinic Terapevticheskii Arkhiv 60(1): 126-128
Gevers Leuven, J.A. 1978: Cholesterol in high density lipoprotein as an anti-risk factor for ischemic heart disease Nederlands Tijdschrift voor Geneeskunde 122(25): 900-904
Wang, Z-jie.; Tian, X-zhi.; Li, X.; Chen, Z.; Zhao, L-cheng.; Zhou, B-fan.; Wu, Y-feng. 2005: Dietary treatment and success rate of control in hypercholesterolemia patients treated with lipid lowering drugs: a multi-center study of current status on clinical control of hypercholesterolemia in China Zhonghua Xin Xue Guan Bing Za Zhi 33(4): 372-375
Sadreddini, S.A.; Abolfathi, A.A.; Khandagi, R.; Talebi, M.; Lakian, A. 2007: C-reactive protein, fibrinogen, lipoprotein (a), and lipid profile levels and platelet counts in ischemic stroke patients Neurosciences 12(3): 202-206
Pearson, T.A.; Laurora, I.; Chu, H.; Kafonek, S. 2000: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Archives of Internal Medicine 160(4): 459-467
Tilly-Kiesi, M.; Tikkanen, M.J. 1992: Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia Journal of Laboratory and Clinical Medicine 120(1): 103-110
Vasil'chenko, E.M.; Beĭko, V.A.; Tymchishin, P.N.; Karpov, R.S. 1989: Changes in the rosette-forming capacity of peripheral blood lymphocytes in patients with ischemic heart disease after administration of atherogenic lipoproteins Kardiologiia 29(2): 53-56
Vedenko, L.T. 1974: Use of RNA synthesis cofactors in complex treatment of patients with ischemic heart disease Vrachebnoe Delo 11: 38-41